Choudhury Monisha, Agrawal Sapna, Pujani Mukta, Thomas Shaji, Pujani Meenu
Department of Pathology, Lady Hardinge Medical College and Smt. Sucheta Kriplani Hospital, New Delhi, India.
Hamdard Institute of Medical Sciences and Research, New Delhi, India.
South Asian J Cancer. 2015 Jan-Mar;4(1):28-31. doi: 10.4103/2278-330X.149946.
The study was conducted to detect occult metastases in lymph node negative breast cancer patients using cytokeratin (CK) and epithelial membrane antigen (EMA) immunohistochemistry (IHC) and correlate this with primary tumor size and grade.
A total of 32 cases including 12 prospective and 20 retrospective cases of axillary lymph node negative breast cancer were studied. CK and EMA IHC were performed to detect micrometastases.
Axillary lymph node metastases were detected in 18.75% of previously node negative cases using CK and EMA IHC. CK was found to be more sensitive for detection of metastases compared to EMA. A highly significant correlation was observed between tumor grade and axillary lymph node metastases detected by CK and EMA. However, no significant correlation was found between tumor size and axillary lymph node metastases detected by IHC.
In the present study, there was an increase of 18.75% in the occult metastases detection rate using CK and EMA. To conclude, IHC detection of occult metastases should be done using CK in all axillary node negative cases, especially in T1 and T2 stage tumors.
本研究旨在利用细胞角蛋白(CK)和上皮膜抗原(EMA)免疫组化(IHC)检测淋巴结阴性乳腺癌患者的隐匿性转移,并将其与原发肿瘤大小和分级相关联。
共研究了32例病例,包括12例前瞻性和20例回顾性腋窝淋巴结阴性乳腺癌病例。采用CK和EMA免疫组化检测微转移。
使用CK和EMA免疫组化在先前淋巴结阴性的病例中检测到腋窝淋巴结转移的比例为18.75%。发现CK在检测转移方面比EMA更敏感。观察到肿瘤分级与通过CK和EMA检测到的腋窝淋巴结转移之间存在高度显著的相关性。然而,未发现肿瘤大小与通过免疫组化检测到的腋窝淋巴结转移之间存在显著相关性。
在本研究中,使用CK和EMA检测隐匿性转移的比率增加了18.75%。总之,对于所有腋窝淋巴结阴性病例,尤其是T1和T2期肿瘤,应使用CK进行隐匿性转移的免疫组化检测。